Issa, G. C., Larson, R. A., Hughes, T. P., Hochhaus, A., Takahashi, N., Bombaci, F., Wang, J., Kim, D.-W., Kim, D. D. H., Mayer, J., Goh, Y.-T., le Coutre, P., Kim, I., Etienne, G., Andorsky, D., Gu, E., Zhang, Y., McCulloch, T., Agrawal, N., Jinwal, R., Damon, A., Sadek, I. and Cortes, J. E. (2020) “Favorable tolerability of asciminib versus ATP-competitive tyrosine kinase inhibitors in the ASC4FIRST study of newly diagnosed patients with chronic-phase chronic myeloid leukemia”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2025.300145.